Showing results (161-170 of 242) with videos related to
Sort By:
Pageof 25
Neuro-Oncology|December 15, 2007
Immunological responses in a patient with glioblastoma multiforme treated with sequential courses of temozolomide and immunotherapy: case studyAmy B Heimberger, Wei Sun, S Farzana Hussain, et al.Oncotarget|November 19, 2013
KMT2D maintains neoplastic cell proliferation and global histone H3 lysine 4 monomethylationChangcun Guo, Lee H Chen, Yafen Huang, et al.Cancer Research|September 5, 2006
AAL881, a novel small molecule inhibitor of RAF and vascular endothelial growth factor receptor activities, blocks the growth of malignant gliomaSith Sathornsumetee, Anita B Hjelmeland, Stephen T Keir, et al.Neuro-Oncology|November 17, 2006
Phase II study of Cloretazine for the treatment of adults with recurrent glioblastoma multiformeMichael A Badruddoja, Kara Penne, Annick Desjardins, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
Bevacizumab plus irinotecan in recurrent WHO grade 3 malignant gliomasAnnick Desjardins, David A Reardon, James E Herndon, et al.The Journal of Biological Chemistry|February 15, 2013
Reversing the Warburg effect as a treatment for glioblastomaEthan Poteet, Gourav Roy Choudhury, Ali Winters, et al.Nature Communications|March 26, 2021
Viral infection of cells within the tumor microenvironment mediates antitumor immunotherapy via selective TBK1-IRF3 signalingMichael C Brown, Mubeen M Mosaheb, Malte Mohme, et al.Journal of Neurochemistry|January 20, 2015
Proteomic profiling of patient-derived glioblastoma xenografts identifies a subset with activated EGFR: implications for drug developmentKristine E Brown, Gustavo Chagoya, Shawn G Kwatra, et al.Cancer|June 19, 2014
Oncolytic polio virotherapy of cancerMichael C Brown, Elena Y Dobrikova, Mikhail I Dobrikov, et al.Oncotarget|November 30, 2010
Integrated genomic analyses identify ERRFI1 and TACC3 as glioblastoma-targeted genesChristopher G Duncan, Patrick J Killela, Cathy A Payne, et al.Pageof 25